Turnstone Biologics, a privately held clinical stage biotech company, is developing breakthrough cancer immunotherapies by advancing two leading and complementary platforms that drive innate and adaptive tumor immunity, to provide benefit to the millions of cancer patients underserved by current treatment options.

Biotechnology

Turnstone Biologics

Sammy Farah

Vijay Chiruvolu

Karen Major

Joseph Campisi

Joel Harris

Ines Verdon

Barbara Sennino

Mike Burgess

Venkat Ramanan

P. Joseph Campisi

Saryah Azmat

The executive team at Turnstone Biologics has experience in consulting, academia, research and development, business development, and venture capital analysis. They have degrees from Chalmers University of Technology, DTU - Technical University of Denmark, University of Bristol, Thayer School of Engineering, and Dartmouth College.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Turnstone Biologics

Board of Directors

Leadership Team